Corporate News     09-Feb-22
Board of Suvan Pharmaceuticals recommends interim dividend
Of Rs.1 per share
Suvan Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 08 February 2022, inter alia, have recommended the interim dividend of Rs.1 per equity share(i.e.100%), subject to the approval of the shareholders.
Previous News
  Suven Pharmaceuticals consolidated net profit declines 56.95% in the March 2024 quarter
 ( Results - Announcements 31-May-24   07:40 )
  Suven Pharmaceuticals consolidated net profit rises 2.34% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Suven Pharmaceuticals update on acquisition of up to 76% stake by Berhyanda, Cyprus
 ( Corporate News - 26-Sep-23   12:12 )
  Suven Pharmaceuticals to hold board meeting
 ( Corporate News - 06-Aug-24   17:05 )
  Suven Pharmaceuticals fixes record date for dividend
 ( Market Beat - Reports 02-Sep-22   14:57 )
  Suven Pharmaceuticals to conduct board meeting
 ( Corporate News - 31-Jan-24   12:06 )
  Suven Pharmaceuticals receives upgrade in credit ratings for bank facilities
 ( Corporate News - 25-Apr-22   14:26 )
  Suven Pharmaceuticals to table results
 ( Corporate News - 22-May-23   12:59 )
  Board of Suvan Pharmaceuticals recommends Interim Dividend
 ( Corporate News - 11-Feb-21   10:52 )
  Shares of Suven Pharmaceuticals gets listed
 ( Corporate News - 09-Mar-20   11:23 )
  Suven Pharmaceuticals Ltd leads losers in 'B' group
 ( Hot Pursuit - 24-Jun-20   14:45 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top